Page last updated: 2024-11-02

oxymetazoline and Di Guglielmo Disease

oxymetazoline has been researched along with Di Guglielmo Disease in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Musgrave, IF1
Seifert, R1

Other Studies

1 other study available for oxymetazoline and Di Guglielmo Disease

ArticleYear
Alpha 2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium.
    Biochemical pharmacology, 1995, Jan-18, Volume: 49, Issue:2

    Topics: Binding, Competitive; Calcium; Cell Fractionation; GTP Phosphohydrolases; GTP-Binding Proteins; Huma

1995